Skip to content
Menu
Menu
Company
Company Profile
Management
Supervisory Board
Partners
Science
Pipeline
TCR T Cells
MDG1015
Publications
Abstracts
Platform
Overview
Target Screening
TCR Generation
TCR-T Therapy Optimization
Manufacturing/Scale-up & Process Improvement
Clinical Development
Investors & Media
Press & Material News Releases
Stock Information
Analyst Coverage
Shareholder Structure
Capital Measures
Reports & Presentations
Corporate Governance
Compliance
Code of Conduct
Whistleblower System
Annual General Meeting
Investor Contact
E-mail Alerts
Careers
Contact
English
Deutsch
Menu
Company
Company Profile
Management
Supervisory Board
Partners
Science
Pipeline
TCR T Cells
MDG1015
Publications
Abstracts
Platform
Overview
Target Screening
TCR Generation
TCR-T Therapy Optimization
Manufacturing/Scale-up & Process Improvement
Clinical Development
Investors & Media
Press & Material News Releases
Stock Information
Analyst Coverage
Shareholder Structure
Capital Measures
Reports & Presentations
Corporate Governance
Compliance
Code of Conduct
Whistleblower System
Annual General Meeting
Investor Contact
E-mail Alerts
Careers
Contact
English
Deutsch
Investor Contact
Tel: +49 89 2000 3333 01
Contact
Pamela Keck
Vice President of Investor Relations and Corporate Communications
investor@medigene.com
This site is registered on
wpml.org
as a development site.